Contents

Recent Patents on Anti-Cancer Drug Discovery, Volume 4 - Number 1

Targeted Delivery of Short Interfering RNAs - Strategies for In Vivo Delivery

, 4(1): 1 - 8

Ulrich Wullner, Inga Neef, Mehmet K. Tur and Stefan Barth


DOI: 10.2174/157489209787002506




Anti-HER2 Treatment and Breast Cancer: State of the Art, Recent Patents, and New Strategies

, 4(1): 9 - 18

Lorenzo Daniele and Anna Sapino


DOI: 10.2174/157489209787002489




Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment

, 4(1): 19 - 27

Yakun Chen and Daotai Nie


DOI: 10.2174/157489209787002498




Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway

, 4(1): 28 - 35

Kwong-Kwok Wong


DOI: 10.2174/157489209787002461




Oncologic Imaging End-Points for the Assessment of Therapy Response

, 4(1): 36 - 53

Natalie J. Serkova, Kavita Garg and Erica L. Bradshaw-Pierce


DOI: 10.2174/157489209787002434




Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine

, 4(1): 54 - 72

Madeleine Hewish, Ian Chau and David Cunningham


DOI: 10.2174/157489209787002515




Proteasome Inhibitors Therapeutic Strategies for Cancer

, 4(1): 73 - 82

Annamaria D'Alessandro, Luisa Pieroni, Maurizio Ronci, Simona D'Aguanno, Giorgio Federici and Andrea Urbani


DOI: 10.2174/157489209787002452




The Potential Anti-Tumorigenic and Anti-Metastatic Side of the Proprotein Convertases Inhibitors

, 4(1): 83 - 91

Rachid Lahlil, Fabien Calvo and Abdel-Majid Khatib


DOI: 10.2174/157489209787002470




The Anti-Cancer Activity of Noscapine: A Review

, 4(1): 92 - 97

Massoud Mahmoudian and Parvaneh Rahimi-Moghaddam


DOI: 10.2174/157489209787002524




Patent Selections

, 4(1): 98 - 100

Bentham Science Publishers


DOI: 10.2174/157489209787002443




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science